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Objectives: Despite improvements in organ preservation, reperfusion injury
remains a major source of morbidity and mortality after lung transplan-
tation. This pilot study was designed to investigate the effects of controlled
reperfusion after lung ischemia. Methods: Twenty adult pigs underwent 2
hours of warm lung ischemia by crossclamping the left bronchus and
pulmonary artery. In five (group 1), the clamp was simply removed at the
end of ischemia (uncontrolled reperfusion). The 15 other pigs underwent
modified reperfusion using blood from the femoral artery to perfuse the
lung through the pulmonary artery (pressure 40 to 50 mm Hg) for 10
minutes before removing the pulmonary artery clamp. In five (group 2), the
blood was mixed with crystalloid, resulting in a substrate-enriched, hy-
pocalcemic, hyperosmolar, alkaline solution. In five (group 3), the blood
was circulated through a leukocyte-depleting filter, and the last five (group
4) underwent reperfusion with both a modified solution and white blood cell
filter. Lung function was assessed 60 minutes after reperfusion, and biopsy
specimens were taken. Results: Controlled reperfusion with both a white
blood cell filter and modified solution (group 4) completely eliminated the
reperfusion injury that occurred with uncontrolled reperfusion (group 1),
resulting in complete preservation of compliance (98% 6 1% vs 77% 6 1%;
p < 0.001, and arterial/alveolar ratio (97% 6 2% vs 27% 6 2%; p < 0.001);
no increase in pulmonary vascular resistance (106% 6 1% vs 198% 6 1%;
p < 0.001); lowered tissue edema (82.1% 6 0.4% vs 84.3% 6 0.2%; p <
0.001), and myeloperoxidase activity (0.18 6 0.02 vs 0.35 6 0.02 dOD/
min/mg protein; p < 0.001). In contrast, using either a white blood cell filter
or modified solution separately improved but did not avoid the reperfusion
injury, resulting in pulmonary function and tissue edema levels that were
intermediate between group 1 (uncontrolled reperfusion) and group 4
(white blood cell filter and modified solution). Conclusion: After 2 hours of
warm pulmonary ischemia, (1) a severe lung injury occurs after uncon-
trolled reperfusion, (2) controlled reperfusion with either a modified
reperfusion solution or white blood cell filter limits, but does not avoid, a
lung reperfusion injury, (3) reperfusion using both a modified reperfusate
and white blood cell filter results in complete preservation of pulmonary
function. We therefore believe surgeons should control the reperfusate after
lung transplantation to improve postoperative pulmonary function. (J Tho-
rac Cardiovasc Surg 1998;115:415-25)
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Since its resurgence in the late 1980s, lung trans-plantation has been accepted as the treatment of
choice for end-stage pulmonary disease. Demand
continues to outpace availability of donor lungs. As
such, the number of lung transplantations per-
formed worldwide has plateaued since 1993.1 Com-
pared with other solid organs, little clinical progress
has been made in using less than perfect lungs and
in prolonging ischemic time. At present, only 10% to
15% of multiorgan donors have lungs suitable for
transplantation, and most institutions do not rou-
tinely accept ischemic time longer than 6 hours.1
Despite these conservative procuremerit practices,
transplanted lungs remain vulnerable to preopera-
tive injury and severe graft dysfunction (reperfusion
injury or reimplantation response) that occurs in
10% to 20% of cases.1-5 Clinically, this syndrome
results in progressive hypoxemia, decreased pulmo-
nary compliance, pulmonary edema, increased pul-
monary vascular resistance (PVR), and diffuse infil-
trates on chest radiographs.1-3 Histologically, these
lungs show alveolar damage, sequestration of neu-
trophils, interstitial edema, and in severe cases,
hemorrhagic infiltrates.6 Although not always fatal,
this syndrome is associated with a prolonged inten-
sive care unit stay and mechanical ventilation, which
has been associated with higher incidence of airway
healing complications.1 This ischemia-reperfusion
injury has also recently been found to predispose
grafts to early rejection by up-regulation of class II
major histocompatibility antigens.7 This up-regula-
tion of inflammatory mediators during the immedi-
ate postoperative period has been shown to not only
play a role in injury to the transplanted lung but also
the deterioration often seen in native lung function
in single lung transplants.8, 9
Understanding and controlling the ischemia-
reperfusion injury seems to be one of the keys to
increasing the available donor pool and improving
short- and long-term outcomes in lung transplanta-
tion. Although it is clear that changes that occur
during ischemia are the trigger, it has become
increasingly evident that most of the injury occurs
during the first few minutes of reperfusion.10-12
Current clinical practices in lung transplantations
are primarily aimed at decreasing damage during
ischemia (i.e., single cold flush perfusion, topical
cooling and inflated cold storage).1, 2 Several exper-
imental studies have, however, been done to try to
minimize the reperfusion injury.4, 13-17 Most have
centered around adding substrates to the flush so-
lution, such as oxygen-derived free radical scaven-
gers, agents that block neutrophil-endothelial inter-
action, or endothelial protective agents. Few of
these additives have gained clinical acceptance.
Much less attention has been paid to directly ma-
nipulating the onset of reperfusion, despite the
documented effectiveness of this approach after
myocardial ischemia.18, 19
The objectives of this pilot study were, therefore,
to determine the effect of using controlled reperfu-
sion in preventing a reperfusion injury after a period
of lung ischemia.
Material and methods
Twenty healthy mature Duroc-Yorkshire pigs (25 to 35
kg) were sedated with intramuscular ketamine (20 mg/kg),
anesthetized with intravenous pentobarbital (25 mg/kg),
and paralyzed with intravenous pancuronium (0.3 mg/kg).
Anesthesia was maintained by intermittent intravenous
pentobarbital. Mechanical ventilation was achieved with a
tracheostomy using a Servo 900-B volume-controlled ven-
tilator (Siemens-Elema, Solna, Sweden). All animals re-
ceived 1 gm of cefazolin intravenously before surgery, and
humane care in compliance with the “Principles of Labo-
ratory Animal Care” formulated by the National Society
for Medical Research and “The Guide for The Care and
Use of Laboratory Animals,” prepared by the National
Academy of Science and published by the National Insti-
tute of Health (NIH publication 96-03, revised 1996).
Heart rate was monitored continuously by electrocar-
diogram. The left femoral artery and vein were cannulated
for continuous monitoring of arterial blood pressure,
blood gas determinations, and intravenous infusions.
Urine output was assessed with an indwelling urinary
catheter. Intravenous furosemide (Lasix), 0.5 to 1 mg/kg,
was given as indicated to maintain urine output greater
than 1 mg/kg per hour. Body temperature was monitored
using esophageal temperature probe (Mon-A-Therm
400H, Mallinckrodt, St. Louis, Mo.) and maintained at 36°
to 38° C with a heating blanket. Periodic arterial blood
samples were drawn and analyzed for blood gas, potas-
sium, ionized calcium, and hemoglobin (Ciba-Corning,
Blood Gas System 288, Medfield, Mass.). Electrolytes
were kept within normal limits, and all animals had an
initial hemoglobin value higher than 10.0 gm/dl.
After a median sternotomy, the pericardium and both
pleural spaces were entered. A 7F balloon-tipped ther-
modilution catheter (Baxter Healthcare Corp., Deerfield,
Ill.) was placed through the right internal jugular vein into
the main pulmonary artery for determination of pressure
and cardiac output. An 18-gauge catheter was placed in
the left atrium for pressure measurements. The right and
left hilar structures (pulmonary arteries, veins, and main
bronchi) were dissected. Special attention was paid to
skeletonizing the left bronchus for a length of approxi-
mately 1 cm, thereby obliterating the bronchial blood
supply. Animals were then given 3 mg/kg heparin intrave-
nously. The right femoral artery and left pulmonary artery
were cannulated using an 8F DLP arterial cannula (DLP,
Inc., Grand Rapids, Mich.). This allowed blood to be
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withdrawn from the femoral artery and, through a roller
pump, passed through either a mixer/heater (BCD, Shiley
Corp, Irvine, Calif.), a leukocyte-depleting filter (WBC
filter) (Pall BC-1, Pall Corp, Glen Cove, N.Y.), or both,
and returned to the pulmonary artery (Fig. 1). A catheter
was also placed to allow constant monitoring of left
pulmonary artery pressure during controlled reperfusion.
Study groups. The animals were divided into four
groups, five in each. The left and right hilar structures
were transiently clamped separately to obtain baseline
pulmonary functional measurements (compliance, arteri-
al/alveolar ratio [a/A ratio], and PVR) for each lung.
Clamps were then placed on the left main-stem bronchus
and left pulmonary artery. The left main-stem bronchus
was clamped to ensure complete warm ischemia by elim-
inating all bronchial blood and lymphatic flow. Ventilation
was adjusted for one-lung ventilation, and the animals
were observed for 2 hours. At the end of 2 hours, the left
lung was reperfused by one of four different methods.
Uncontrolled reperfusion
GROUP I (UNMODIFIED BLOOD). The clamps were simply
removed from the pulmonary artery and bronchus, allow-
ing unmodified blood to reperfuse the lung by restoring
native pulmonary flow.
Controlled reperfusion
GROUP II (MODIFIED SOLUTION). The left lung was
reperfused by taking blood from the femoral artery,
mixing it in a 4:1 ratio with a modified crystalloid solution
(Table I), and then pumping this solution into the left
pulmonary artery distal to the clamp for 10 minutes (Fig.
1). The reperfusate was allowed to return to the pig by way
of the pulmonary vein. Perfusion pressure was continu-
ously monitored and kept between 40 and 50 mm Hg in
the distal pulmonary artery. This resulted in blood flows
between 50 and 70 ml/min. After 10 minutes, the con-
trolled perfusion was stopped, and the pulmonary artery
and bronchial clamps were removed, restoring native
pulmonary circulation.
Fig. 1. A, Our experimental model of controlled pulmonary reperfusion. Blood is taken from the femoral
artery and combined with either a modified crystalloid solution using a BCD as a mixer, passed through a
WBC filter before being returned to the pulmonary artery, or both. The pressure in the distal pulmonary
artery is constantly measured and kept between 40 and 50 mm Hg. B, The modified reperfusate is infused
into the left pulmonary artery distal to the clamp and is able to return to the pig through the pulmonary
veins.
Table I. Modified reperfusate solution
Solution additive
Volume
added (ml)
Component
modified
Concentration
delivered*
MgCl2 (2 mEq/L) 24 Mg
12 10-12 mEq/L
THAM (0.3 mol/L) 225 pH pH 7.5-7.6
CPD 225 Ca12 0.2-0.3 mmol/L
Aspartate/glutamate 250 Substrate 13 mmol/L
each
D50W 40 Glucose .400 mg/dl
D5W 200 Osmolarity 380-400 mOsm
Nitroglycerin
(5 mg/ml)
1 Vasodilator 1 mg/ml
Tham, Tromethamine; CPD, citrate-phosphate-dextrose; D50W, 50% dex-
trose in water.
*When mixed in a 4:1 ratio with blood.
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GROUP III (WBC FILTER). The left lung was reperfused
by taking blood from the femoral artery, passing it
through a WBC filter (Pall BC-1), and then pumping it
into the left pulmonary artery distal to the clamp for 10
minutes (Fig. 1). The pressure was again continuously
monitored and kept between 40 and 50 mm Hg in the
distal pulmonary artery. After 10 minutes, the perfusion
was stopped and the clamps removed, restoring native
pulmonary blood flow.
GROUP IV (WBC FILTER AND MODIFIED SOLUTION).
Perfusion was the same as in groups 2 and 3, but both a
WBC filter and modified solution were used during the
first 10 minutes of reperfusion. The clamps were then
removed as above.
All animals were observed for 1 hour after reperfusion
and functional measurements were repeated in the left
and right lungs. Bilateral lung biopsy specimens were then
obtained for tissue edema and myeloperoxidase activity,
and the animals euthanized.
Pulmonary functional measurements. Pulmonary func-
tional measurements were obtained for each lung by
transiently clamping the contralateral bronchus and pul-
monary artery so all blood flow and ventilation were
directed through the lung being assessed. All measure-
ments were obtained before ischemia (baseline) and 60
minutes after reperfusion. Postreperfusion measurements
are expressed as a percentage of baseline to allow each pig
to act as its own control.
ARTERIAL/ALVEOLAR RATIO. With ventilation un-
changed between preischemic and postreperfusion set-
tings, the a/A oxygen ratio for each lung was calculated
using the following formula:
a/A tension ratio 5
PO2
FiO2 (PB 2 PH2O) 2 PCO2 (1.25 2 0.25 FiO2)
where PO2 is partial pressure of oxygen, FiO2 is inspired
percentage of oxygen, PCO2 is partial pressure of carbon
dioxide, PB is barometric pressure, and PH2O is partial
pressure of water.
PVR. Cardiac output was measured using a Swan-Ganz
catheter and a Edwards 9502 computer (Baxter Health-
care Corp., Edwards Division, Santa Ana, Calif.). Aver-
ages from three measurements were used. PVR was
calculated using the following formula:
PVR ~dynes 3 sec21 3 cm25! 5
PAP – LAP
CO
3 80
where PAP is mean pulmonary artery pressure, LAP is
mean left arterial pressure, and CO is cardiac output.
LUNG COMPLIANCE. Peak airway pressure was measured
using a tidal volume of 15 ml/kg without positive end-
expiratory pressure. Static compliance was calculated as
change in volume/change in pressure (ml/cm H2O).
Tissue measurements
LUNG EDEMA. A wedge biopsy was taken from the
inferior portion of the right and left upper lobes at the end
of the experiment for tissue water and myeloperoxidase
activity. A portion of each biopsy specimen was weighed
and then dried to a constant weight at 80° to 85 °C. Results
are expressed as percentage tissue water using the follow-
ing formula:
%Tissue water 5
Wet weight – Dry weight
Wet weight
3 100
MYELOPEROXIDASE ACTIVITY. The other portion of each
biopsy was immediately frozen and stored in liquid nitro-
gen. The frozen tissue was then crushed using a liquid
nitrogen–cooled motor and pestle, and lyophilized (Sa-
vant Speed Vac Systems, Farmingdale, N.Y.). Quantita-
tive myeloperoxidase activity was determined using the
modified procedures of Okabayashi and associates.20 Ten
to 15 mg of dry lung tissue was homogenized in 1 ml of
0.5% hexadecyltrimethylammonium bromide (to release
myeloperoxidase from the cells), 5 mmol/L EDTA, and 50
mmol/L potassium phosphate buffer (pH 6.2) with Kontes
glass tissue grinder (Kontes Glass Co, Vineland, N.J.).
The homogenate was centrifuged at 10,000g for 15 min-
utes at 4° C. The supernatant was assayed for total soluble
protein by the method of Pierce Laboratories.21 Fifty
microliters of supernatant was combined with 0.6 ml
Hanks bovine serum albumin, 0.5 ml of 100 mmol/L
potassium phosphate buffer (pH 6.2), 0.1 ml 0.05% H2O2,
and 0.1 ml of 1.25 mg/ml o-dianisidine. The optical density
was measured at 460 nm (Beckman DU7400, Beckman
Instruments, Inc., Fullerton, Calif.). Color development
from 5 to 20 minutes is linear. Enzyme activity is ex-
pressed as the change in optical density units per minute
per milligram of tissue protein (dOD/min/mg protein).
WBC count and platelet counts. WBC and platelet
counts were obtained from animals in which a WBC filter
was used (Sysmex K- 100, Baxter, Deerfield, Ill.). Differ-
ential counts were performed manually by a single tech-
nician. Leukocyte and platelet counts were obtained prox-
imal and distal to the WBC filter during reperfusion and
expressed as cells 3 1000/mm3 per cubic millimeter.
Statistical analysis. Data were analyzed using JMP
V2.0 (SAS Institute Inc., Cary, N.C.) on a Macintosh
IIVX Computer (Apple Inc., Cupertino, Calif.). All data
are expressed as mean 6 standard error of the mean.
Paired Student’s t test and two-way analysis of variance
with interaction (factorial analysis) were used for compar-
ison of variables among experimental groups. If analysis of
variance revealed a significant interaction, pair-wise tests
of individual group means were contrasted by way of
multiple comparisons (Tukey’s test) using a level of
significance of p , 0.01.
Results
No statistical difference was found in baseline
(preischemic) measurements of compliance (14.8 6
0.3 ml/cm H2O), PVR (959 6 14 dynes/sec/cm), or
a/A ratio (0.78 6 0.03) between any group. All
animals remained stable throughout this experi-
ment.
Pulmonary function. Results are summarized in
Figs. 2 to 4 and Table II. All postoperative values
are expressed as a percentage of baseline measure-
ments to allow each pig to act as its own control.
After 2 hours of ischemia, uncontrolled reperfusion
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(group 1) caused a significant pulmonary injury
manifested by decreased compliance, elevated PVR,
and decreased oxygenation (a/A ratio). In contrast,
this injury was essentially avoided by controlling
pulmonary reperfusion using a modified solution
and WBC filter (group 4), resulting in complete
preservation of compliance, PVR, and oxygenation
(a/A ratio). Use of only one of these modalities
(modified solution, group 2; or WBC filter, group 3)
resulted in intermediate preservation of pulmonary
function, implying that the reperfusion injury was
only partially modified.
In the nonischemic right lung, no significant
change occurred in postoperative pulmonary func-
Fig. 2. Postreperfusion pulmonary compliance expressed as percent recovery compared with baseline
values. Uncontrolled reperfusion with unmodified blood significantly lowered pulmonary compliance,
indicating a reperfusion injury. Controlled reperfusion with either a modified solution or WBC filter
partially blunted this injury but did not fully restore pulmonary compliance. Conversely, using both a WBC
filter and modified solution avoided the reperfusion injury, resulting in complete recovery of pulmonary
compliance. *p , 0.01 versus uncontrolled reperfusion. **p , 0.001 versus all other groups.
Fig. 3. Postreperfusion PVR expressed as percent increase compared with baseline values. The PVR
doubled when the lung was reperfused in an uncontrolled fashion using unmodified blood. Conversely, this
increase was lessened by using controlled reperfusion with either a modified solution or WBC filter alone.
However, the reperfusion injury was only completely avoided when both a WBC filter and modified
solution were combined. Indeed, in this group, there was no increase in PVR compared with preischemic
values. *p , 0.001 versus uncontrolled reperfusion. **p , 0.001 versus all other groups.
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tion (compliance, PVR, a/A ratio) in any group
undergoing controlled reperfusion (groups 2
through 4). In contrast, when the left (ischemic)
lung underwent uncontrolled reperfusion (group 1),
slight deterioration of pulmonary function in the
right (nonischemic) lung compared with baseline
was noted (compliance 96% 6 1%, PVR 111% 6
2%, a/A ratio 95% 6 2%), suggesting it had sus-
tained a mild pulmonary injury from metabolic
products liberated during reperfusion of the isch-
emic left lung.
Biochemical analysis. Results are summarized in
Table II and follow the same trends as functional
results. The highest rise in lung edema and myelo-
peroxidase activity, once again, occurred with un-
controlled reperfusion of the ischemic left lung,
implying the greatest injury. These changes were
completely prevented by modifying the reperfusate
with a WBC filter and a modified solution (group 4)
and partially altered if only one reperfusate modal-
ity (modified solution group 2 or WBC filter group
3) was used.
In the nonischemic right lung, tissue edema
(83.2% 6 0.2% vs 81.5% 6 0.1%, p , 0.001) and
myeloperoxidase activity (0.33 6 0.02 vs 0.19 6 0.01,
p 5 0.003) were significantly higher after uncon-
trolled reperfusion (group 1) compared with pigs
receiving a controlled reperfusate with a WBC filter
and modified solution (group 4). This further im-
plies that the contralateral lung is injured by metab-
Fig. 4. Postreperfusion a/A oxygen ratio expressed as percent recovery of baseline values. Uncontrolled
reperfusion using unmodified blood resulted in a marked decrease in a/A ratio, indicating a reperfusion
injury. This injury was partially avoided by using either a WBC filter or modified solution alone and was
completely avoided using controlled reperfusion with both a WBC filter and modified solution. *p , 0.01
versus uncontrolled reperfusion. **p , 0.01 versus all other groups.
Table II. Left lung functional and tissue results
Reperfusion
method Compliance (%) PVR (%) a/A ratio (%) Lung water (%) Myeloperoxidase
Uncontrolled
(Group 1) 77 6 1* 198 6 1 27 6 2 84.3 6 0.2 0.35 6 0.02
Modified solution
(Group 2) 86 6 1* 153 6 2* 51 6 1* 83.4 6 2* 0.21 6 0.03*
WBC filter
(group 3) 91 6 1* 133 6 1† 77 6 2† 83.3 6 2* 0.17 6 0.01*
Solution and filter
(group 4) 98 6 1‡ 106 6 1‡ 97 6 2‡ 82.1 6 0.4‡ 0.18 6 0.02*
F 5 5.7, p , 0.03 F 5 142, p , 0.001 F 5 11.8, p , 0.004 F 5 98, p , 0.0001 F 5 9.7, p , 0.007
*p , 0.01 vs group 1 (uncontrolled reperfusion).
†p , 0.01 vs group 1 and group 2.
‡p , 0.01 vs all groups.
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olites released during uncontrolled reperfusion of
the ischemic left lung.
WBC and platelet counts. The WBC (pre 17.5 6
1.2 vs post 0.4 6 0.1 WBCs 3 1000/mm3; p , 0.001)
and neutrophil (pre 12.2 6 1.1 vs post 0.3 6 0.1
neutrophils 3 1000/mm3; p , 0.001) counts were
significantly decreased by the WBC filter. Platelet
counts also decreased but to a lesser extent (pre
437 6 18 vs post 281 6 19 platelets 3 1000/mm3;
p , 0.001).
Discussion
These data indicate that after 2 hours of warm
pulmonary ischemia, a severe lung injury occurs with
uncontrolled reperfusion, this injury is minimized
but not avoided by using either a modified solution
or WBC filtration, and that using both a modified
solution and a WBC filter results in complete pres-
ervation of pulmonary function. These findings are
almost identical to results with controlled reperfu-
sion after myocardial ischemia and support the
importance of applying these concepts after lung
ischemia.18, 19
Ischemia-reperfusion injury remains a significant
problem in lung transplantation.1-3 Recent studies
have shown that injury to the endothelial cell may be
the trigger that eventually leads to total organ
failure, but the cause of this injury is multifactori-
al.11, 12, 22 Although the dysfunction begins during
ischemia, it is significantly enhanced and accelerated
by reperfusion.5, 19, 23 One reason is that the inevi-
table restoration of oxygen during reperfusion leads
to formation and activation of a variety of humoral
mediators of injury and inflammation.5 These hu-
moral factors cause an initial endothelial dysfunc-
tion that leads to marked reduction in nitric oxide
and prostaglandin release.5 That along with che-
motactic factors (PAF, LTB4, CSa) and up-regu-
lation of adhesive molecules on the endothelial
cell (ICAM-1, ECAM-1, GMP140) accentuates
adherence of neutrophils to the endothelium and
diapedesis into the organ.1, 5, 24 Activated neutro-
phils release a host of proinflammatory mediators
that promote cell injury and amplify initial endo-
thelial dysfunction.5, 23, 25 Several pharmacologic
agents are known that can block the endothelial
injury. Many of these have been studied, including
adding different neutrophil adhesives molecule
blocking monoclonal antibodies to the initial
flushing solution or giving some of the deficient
chemicals, such as, nitric oxide, during reperfu-
sion.13, 26, 27
Because controlling the conditions of reperfusion
and the composition of the reperfusate have been
shown to modify the reperfusion injury in myocar-
dial tissue, this study investigates whether applica-
tion of these principles can prevent the reperfusion
injury after pulmonary ischemia. We used a clini-
cally relevant (in vivo) model because most studies
of lung reperfusion have been done using isolated
preparations, making extrapolation of results from
these studies to clinical practice difficult.
WBC filter. Use of an efficient WBC filter (Pall
BC-1) removed over 95% of leukocytes in one
passage in all pigs. However, in comparison with
some other filters only approximately 60% of the
platelets were removed. Breda and associates16, 17
were the first to show that leukocyte depletion
during reperfusion decreased lung injury after isch-
emia. By use of a variety of experimental models,
these observations have been confirmed after both
short-term warm ischemia and 24 hours of cold
storage.2, 6, 24, 28 Several other studies have used
various neutrophil-modulating agents to demon-
strate that WBCs play a major role in reperfusion
injury of the lung.27, 28 Steimle and associates,29 on
the other hand, found that profound neutropenia
did not fully protect an organ from an ischemia-
reperfusion injury. Therefore the reperfusion injury
appears to be complex, consisting of both neutro-
phil-independent and neutrophilic-mediated events.
Our results concur with that conclusion. We found
that WBC depletion did not fully prevent this injury
but significantly blunted the inflammatory cascade.
Several studies performed using an isolated prepa-
ration have raised the question of whether WBC
depletion for a longer period of time may be neces-
sary for full benefits. This question is not addressed
by our results, and further studies using an in vivo
model need to be done to determine the optimal
length of leukocyte-depleted reperfusion.
From a clinical standpoint, the two major con-
cerns of the WBC filtrations have been the possible
increased rate of infection, especially in the setting
of immunosuppression, and the concomitant plate-
let depletion. However, with our method of reper-
fusion, the total body WBC and platelet counts are
minimally affected because only approximately 20%
to 30% of the pigs’ total blood volume is filtered,
and platelet elimination with this filter is only about
60%. Recent studies have also demonstrated that
neutrophil depletion during surgery may actually
decrease the infection rate and that neutrophil
levels quickly return to normal levels once the filter
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is removed.30 It is therefore unlikely that this poses
a problem.
Modified reperfusate solution. Despite compel-
ling evidence that the biochemical composition, as
well as cellular constituents of reperfusate solutions,
significantly affect the amount of ischemia-reperfu-
sion injury in the heart, kidney, and peripheral
muscle, few attempts have been made to apply this
knowledge to lung transplantation.18, 19 Several
studies have been done adding cytoprotective, oxy-
gen radical scavengers or neutrophilic inhibitors to
the recipient’s blood before reperfusion.6, 23 Serrick
and associates,15 recognizing the importance of the
initial reperfusion and the detrimental effects of
uncontrolled blood reperfusion, studied the effects
of a rinse solution before reperfusion. They found
that using an extracellular solution with additives,
including antioxidants, before reperfusion signifi-
cantly increased viability of endothelial cells versus
uncontrolled blood reperfusion. Others found that
10 minutes of hemodilute reperfusion after ischemia
significantly decreased the lung injury.4
The composition of our modified reperfusion
solution was based on principles established in
myocardial tissue, with each component addressing
one of the adverse effects of ischemia/reperfusion.
To counteract acidosis, the solution was made alka-
lotic using the intracellular buffer THAM. Because
calcium is one of the primary mediators of the
reperfusion injury, calcium levels were decreased by
adding citrate, and the solution was enriched with
magnesium to prevent calcium influx. The substrates
aspartate, glutamate, and glucose were used to
replenish depleted energy stores. The solution was
made hyperosmolar to limit edema formation, and
nitroglycerin was added to dilate vascular endothe-
lium that might be damaged from ischemia, thus
improving perfusate distribution. Finally, it was
mixed with blood in a 4:1 ratio to provide oxygen
and endogenous buffers and oxygen radical scaven-
gers. Although the solution therefore resembles our
cardioplegic solution, it has been modified for the
lung. It is obvious from our results that the compo-
sition of the initial perfusate, even without leukope-
nia, plays an integral part in preventing the reper-
fusion injury. This is very similar to the findings in
other organs, especially the myocardium where
modified reperfusates are used routinely in heart
operations.18 No doubt exists that the composition
of the perfusate used for controlled lung reperfusion
is going to change. The effects of several additives,
such as, exogenous oxygen radical scavengers, vaso-
dilators, calcium channel blockers, nitric oxide pre-
cursors, and other agents, need to be investigated.
Also, the optimal amount of hemodilution and
length of controlled reperfusion is unknown. These
and other technical refinements in the method of
controlled reperfusion will remain a fertile ground
for enthusiastic investigators in the near future.
Pressure. Besides changing the reperfusate com-
position with leukocyte depletion and a modified
solution, the conditions of reperfusion were con-
trolled by fixing the perfusate pressure between 40
and 50 mm Hg. This may have helped modify the
reperfusion injury. However, because only group 4
(WBC filter and modified solution) recovered com-
plete function, controlling perfusion pressure does
not by itself explain these results. Indeed, the mag-
nitude of its effect cannot even be gauged from this
study because variations in perfusion pressure were
not investigated. Furthermore, simply removing the
clamps and allowing uncontrolled reperfusion
(group 1) resulted in similar mean pulmonary reper-
fusion pressures (30 to 50 mm Hg), and yet these
animals sustained a severe pulmonary injury. Re-
duction of reperfusion injury by controlling reperfu-
sion pressure is well recognized in the heart and
lung.4, 18, 19 Bhabra and associates4 showed that
controlling the pressure during the first 10 minutes
of pulmonary reperfusion significantly improved
graft function, independent of storage medium or
ischemic time. They also found that this beneficial
effect was not achieved with a shorter period of
controlled reperfusion and that a longer period had
no added effect. Why controlled pressure during
reperfusion has a protective effect is not fully
known. Hydrostatic pressure resulting in rapid
edema, shear stress, and vasomotor dysfunction
have been implicated. Whatever causes the injury, it
seems that during the low-pressure period, the
endothelium recovers sufficiently to subsequently
tolerate full pressure perfusion. We chose a pressure
between 40 and 50 mm Hg because it is what has
been shown to be effective in the heart, and this was
the pressure that resulted with uncontrolled reper-
fusion. However, because the normal pulmonary
pressure is usually substantially lower, perhaps this
pressure is too high and actually exacerbated the
injury. Whether lower pressures would be even
more beneficial must be balanced by the need to
deliver a minimal amount of modified perfusate to
the lung and allow for adequate distribution. The
optimal perfusion pressure and the amount of its
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importance in reducing this injury is, therefore,
another area for investigation.
Finally, we found, as did Watanabe and associ-
ates,9 that the contralateral (nonischemic) right lung
also sustained an injury after uncontrolled reperfu-
sion of the ischemic left lung. This was evident by
5% to 10% worsening of right lung function and the
increase in tissue edema and myeloperoxidase activ-
ity. Conversely, the injury to the contralateral (non-
ischemic) right lung was almost completely pre-
vented with controlled reperfusion (groups 2
through 4). This strongly suggests that metabolic
by-products liberated as a result of the reperfusion
injury play a significant role in the contralateral lung
injury and that controlled reperfusion of the isch-
emic lung prevents this from happening.
In conclusion, our study strongly suggests that the
ischemia-reperfusion injury can be significantly de-
creased by modifying the perfusate, controlling the
perfusion pressure, and filtering white blood cells
during the first 10 minutes of reperfusion. Because
the existence of a reperfusion injury continues to
plague surgeons after lung transplantation, this
study suggests that reperfusion should always be
controlled after pulmonary ischemia. Additional
investigations are needed to verify these results after
long-term cold storage and further refine our
method. Because this study was done using a clini-
cally relevant model, this technique can be used in
human transplant recipients.
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Discussion
Mr. John H. Dark (Newcastle Upon Tyne, United King-
dom). What was the pressure of the reperfusion in the
control group?
Dr. Halldorsson. We used a pressure between 40 and 50
mm Hg, which gave us a flow of approximately 50 ml/min.
Mr. Dark. In the uncontrolled group, the group who
had no separate reperfusion, where you simply removed
the clamp, did you measure the pressure in that group?
Dr. Halldorsson. Yes. After the clamps were removed,
it was simply the pressure in the native pulmonary artery
which had a mean of 30 to 50 mm Hg. The pressure was
therefore similar to the group undergoing controlled
reperfusion. Since we did not control the reperfusate,
however, we are unsure how much flow was directed to
the ischemic lung compared to the nonischemic lung.
Mr. Dark. So in addition to the solution, you are also
addressing the aspect of pressure-controlled reperfusion?
Dr. Halldorsson. Correct. I did not emphasize that
point, but we believe that controlling the pressure during
the initial period of reperfusion is also important in
preventing the reperfusion injury. In this study, we chose
a pressure of 40 to 50 mm Hg for the controlled reperfu-
sate based on what we found worked well in ischemic
myocardium. Since the normal pulmonary artery pressure
is usually lower than the myocardial perfusion pressure, it
is possible that a lower pressure would improve results
and this is currently an area of investigation. This must,
however, be balanced with the knowledge that a lower
perfusion pressure may not allow adequate distribution of
the reperfusate.
Mr. Dark. A second question is how long do you think
you should put the WBC filter in the circuit? We have
used a very similar experimental model with a WBC filter
of 30 minutes.
Dr. Halldorsson. That question remains unanswered.
We chose 10 minutes on the basis of our experience in
myocardial tissue and several reports after pulmonary
ischemia. However, we previously found that longer peri-
ods of controlled reperfusion were beneficial in the myo-
cardium, and so you may be right that the controlled
reperfusate should be delivered over a longer period of
time. This is another current area of investigation.
Mr. Dark. Did you observe WBC sequestration even
after removing the filter from the circuit?
Dr. Halldorsson. We have no way of knowing as we only
examined the tissue for myeloperoxidase activity at the
end of the experiment.
Mr. Dark. Thank you very much. I might add that we
have repeated a very similar set of experiments with an
orthotopic transplant model. You can duplicate all the
benefits of control-pressure reperfusion and the WBC
filter by giving pentoxifylline.
Dr. Halldorsson. Thank you for your comments, but we
would disagree. We do not believe any one drug can
completely prevent the reperfusion injury, as it is a
complex injury that must be addressed by a multifaceted
approach. Our method of using controlled reperfusion to
prevent reperfusion damage is based on our extensive
experimental and clinical experience after myocardial
ischemia. In these studies, we investigated many facets of
controlled reperfusion and found each principle to be
important. Omitting any one of these principles resulted
in decreased myocardial recovery. This study further
supports this belief, as the best results were achieved only
when all aspects of pulmonary reperfusion were con-
trolled (group 4). Although several drugs such as pentoxi-
fylline are known to block WBC function, and could be
used instead of leukocyte depletion, this would only
address one aspect of this multifacted injury. In this study,
we chose to use a WBC filter, since they have been proven
clinically to be very effective without the potential com-
plications of pharmacologic agents.
Dr. G. Alexander Patterson (St. Louis, Mo.). I would be
interested in your speculation as to what you think the
mechanism of this benefit is. At the recent meeting of the
International Society for Heart and Lung Transplantation
(ISHLT), the Toronto group presented a very nice exper-
iment that showed a significant structural injury in lungs
that were reperfused, uncontrolled, versus those that were
reperfused more gradually. Perhaps all this is structural
and does not have a lot to do with white cells. If I
remember your slide correctly, myeloperoxidase assay was
similar with or without the filter. This suggests that the
filter really did not make any difference in terms of
leukocyte sequestration.
Dr. Halldorsson. That’s correct.
Dr. Patterson. Why do you think this works?
Dr. Halldorsson. The ischemic reperfusion injury is
extremely complex, so it is unlikely that controlling a
single variable will prevent all the detrimental effects of
reperfusion. On the basis of this study, as well as our
studies after myocardial ischemia, we believe that it is
important to control all aspects of reperfusion. The trans-
plant surgeon is in the unique position to counteract the
potential reperfusion damage since both the condition of
reperfusion and the composition of the reperfusate are
under the surgeon’s direct control. We controlled the
composition of the reperfusate by using a leukodepleted
modified solution, and the conditions of reperfusion by
regulating the pressure and flow. Since ischemia and
reperfusion damage cells by numerous pathways, we try to
address each adverse effect independently. The reperfu-
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sate solution is therefore alkalotic to counteract the acidosis
that occurs with ischemia; since excess calcium can be
detrimental, the solution is made hypocalcemic with citrate,
and magnesium added to prevent calcium influx; we added
the substrates aspartate, glutamate, and glucose to replenish
depleted energy stores; to prevent edema, the solution is
hyperosmolar; and lastly, nitroglycerin is added to improve
distribution of the solution. White cells are depleted, as they
are detrimental via numerous mechanisms. We also con-
trolled the reperfusion pressure as ischemic cells are more
susceptible to a high pressure injury.
We believe it is careful attention to all of these aspects
of reperfusion that allowed complete return of pulmonary
function. Each is important and exclusion of any will
significantly increase reperfusion damage.
Dr. Larry R. Kaiser (Philadelphia, Pa.). In your control
group, in your injury group, how long did you follow those
animals, and was there any reversal in the injury?
Dr. Halldorsson. In this study, all measurements were
done 1 hour after reperfusion. In another study, how-
ever, we did follow animals for 4 hours and found there
was no improvement with uncontrolled reperfusion. In
contrast, animals undergoing a controlled reperfusion
showed a slight improvement in pulmonary function
after 4 hours.
Dr. Nasser K. Altorki (New York, N.Y.). In the modified
perfusion only, you showed some blunting of the reperfu-
sion injury. Is that a benefit of improved rheology, or is it
just dilution of the granulocytes?
Dr. Halldorsson. Our reperfusate solution is mixed 4
parts blood to 1 part crystalloid, so there is minimal WBC
dilution or change in viscosity. It is therefore doubtful that
this explains our findings. Furthermore, even in the ab-
sence of leukodepletion, modifying the conditions (pres-
sure) and composition (solution) of the reperfusate re-
duced the reperfusion injury in both pulmonary and
myocardial tissue. We therefore believe each principle of
reperfusion is important, and only by completely control-
ling the period of reperfusion can optimal pulmonary
myocardial function be obtained.
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